search
Back to results

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

Primary Purpose

Alzheimer Disease, Mild Cognitive Impairment

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
A Program of SUPPORT-D (dementia)
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Alzheimer Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG.

  • Persons with Alzheimer's Disease (we anticipate cognitive impairment within this group)
  • 18 years old or older
  • Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease within prior 12 months (FAST score < 3)
  • Able to read and speak English (intervention in English)

Caregivers (CG)

  • > 18 years old
  • Non-paid (eliminates professional caregivers)
  • Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report)
  • Able to read and speak English (written materials in English)
  • No diagnosis of cognitive impairment

Exclusion Criteria:

  • Inability or unwillingness to provide informed consent

Sites / Locations

  • Medical University of South CarolinaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

SUPPORT-D Group

Arm Description

Outcomes

Primary Outcome Measures

Change in Alzheimer's Disease Knowledge Scale (ADKS) score
30 items (T/F) summed total of correct items higher score indicates higher knowledge (scores range from 0-30)
Acceptability of Intervention Measure (AIM) score
4 items (5 point Likert scale) average score across items higher score indicates more acceptability of intervention (raw score ranges from 4-20)
Change in feasibility score
4 items (5 point Likert scale) average score across items higher score indicates greater feasibility of intervention (raw scores range from 4-20)
Change Zarit caregiver burden score
12 items (4 point Likert scale) summed score with higher scores indicating greater caregiver distress (raw scores range from 0-48)
Change in Perceived Stress scale score
10 items (4 point Likert scale) summed score across items with higher scores indicate greater levels of stress (scores range from 0-40)
Change in Symptom burden physical function score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased physical function (raw scores range from 4-20)
Change in Symptom burden anxiety score
4 item scale (4 point Likert scale) Standard t scores with higher scores indicating increased anxiety (raw scores range from 4-20)
Change in Symptom burden depression score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased depression (raw scores range from 4-20)
Change in Symptom burden fatigue score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased fatigue (raw scores range from 4-20)
Change in Symptom burden sleep quality score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased sleep quality (raw scores range from 4-20)
Change in Symptom burden satisfaction with social role score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased satisfaction with social role (raw scores range from 4-20)
Change in Symptom burden pain score
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased pain (raw scores range from 4-20)
Change in Quality of life-Alzheimer's Disease (QoL-AD) score
13 items (4 point Likert scale) summed score across items with higher scores indicating better quality of life (scores range from 13-54)
Change in self-efficacy for caregiving score
8 items rated from 1-10 mean score across items with higher scores indicating higher self-efficacy (raw scores range from 8-80)
Change in Safety assessment scale score
32 items summed score across items with higher scores indicating higher risk for accidents (scores range from 11-47)
Change in technology literacy score
21 items (4 point Likert scale) summed scores across items with higher scores indicating better digital health literacy (scores range from 21-84)
Number of participants completing advance care planning documents
Number of participants who complete advance care planning documents
Appropriateness of Intervention score
4 items (5 point Likert scale) average score across items higher score indicates greater appropriateness of intervention (scores range from 4-20)

Secondary Outcome Measures

Full Information

First Posted
August 9, 2022
Last Updated
August 15, 2023
Sponsor
Medical University of South Carolina
Collaborators
National Center for Advancing Translational Sciences (NCATS)
search

1. Study Identification

Unique Protocol Identification Number
NCT05501119
Brief Title
SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers
Official Title
Palliative Care Telehealth Delivered Program of SUPPORT-D Intervention for Persons With Alzheimer's Disease and Caregivers Phase 2
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 27, 2023 (Actual)
Primary Completion Date
October 31, 2023 (Anticipated)
Study Completion Date
December 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of South Carolina
Collaborators
National Center for Advancing Translational Sciences (NCATS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research is pilot test a nurse led intervention previously used in patients with pulmonary fibrosis and their caregivers in a new population (persons living with Mild Cognitive Impairment or Alzheimer's disease and their caregivers. The researchers hypothesize improving advanced care planning in this population will result in enhanced quality of life over illness trajectory and improve safety for community dwelling PWD/CG dyads. Findings from this study will inform additional necessary adaptations required prior to conducting larger scale powered randomized control trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease, Mild Cognitive Impairment

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SUPPORT-D Group
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
A Program of SUPPORT-D (dementia)
Intervention Description
The SUPPORT-D intervention consists educational materials will be presented in a format with enhanced content (face-to-face virtually delivered by nurse interventionist via telehealth (e.g., MS Teams), with printed booklet, and identical digital content (electronic pdf and recorded videos of printed content). The SUPPORT-D intervention will be addressed in four sequential sections including: 1) understanding the disease 2) caring for myself; 3) information for the caregiver; and 4) planning for the future. Within the four sections of the intervention seven topics are addressed included symptom management, understanding your disease, putting safety first, ongoing conversations, respite care, palliative care, and alternative treatments. Participants will attend a total of 4 study visits across 8 weeks (approximately every 2 weeks).
Primary Outcome Measure Information:
Title
Change in Alzheimer's Disease Knowledge Scale (ADKS) score
Description
30 items (T/F) summed total of correct items higher score indicates higher knowledge (scores range from 0-30)
Time Frame
baseline, at study completion, an average of 8 weeks
Title
Acceptability of Intervention Measure (AIM) score
Description
4 items (5 point Likert scale) average score across items higher score indicates more acceptability of intervention (raw score ranges from 4-20)
Time Frame
at study completion, an average of 8 weeks
Title
Change in feasibility score
Description
4 items (5 point Likert scale) average score across items higher score indicates greater feasibility of intervention (raw scores range from 4-20)
Time Frame
at study completion, an average of 8 weeks
Title
Change Zarit caregiver burden score
Description
12 items (4 point Likert scale) summed score with higher scores indicating greater caregiver distress (raw scores range from 0-48)
Time Frame
baseline, at study completion, an average of 8 weeks
Title
Change in Perceived Stress scale score
Description
10 items (4 point Likert scale) summed score across items with higher scores indicate greater levels of stress (scores range from 0-40)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden physical function score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased physical function (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden anxiety score
Description
4 item scale (4 point Likert scale) Standard t scores with higher scores indicating increased anxiety (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden depression score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased depression (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden fatigue score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased fatigue (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden sleep quality score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased sleep quality (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden satisfaction with social role score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased satisfaction with social role (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Symptom burden pain score
Description
4 item scale (5 point Likert scale) Standard t scores with higher scores indicating increased pain (raw scores range from 4-20)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Quality of life-Alzheimer's Disease (QoL-AD) score
Description
13 items (4 point Likert scale) summed score across items with higher scores indicating better quality of life (scores range from 13-54)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in self-efficacy for caregiving score
Description
8 items rated from 1-10 mean score across items with higher scores indicating higher self-efficacy (raw scores range from 8-80)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in Safety assessment scale score
Description
32 items summed score across items with higher scores indicating higher risk for accidents (scores range from 11-47)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Change in technology literacy score
Description
21 items (4 point Likert scale) summed scores across items with higher scores indicating better digital health literacy (scores range from 21-84)
Time Frame
baseline and at study completion, an average of 8 weeks
Title
Number of participants completing advance care planning documents
Description
Number of participants who complete advance care planning documents
Time Frame
at study completion, an average of 8 weeks
Title
Appropriateness of Intervention score
Description
4 items (5 point Likert scale) average score across items higher score indicates greater appropriateness of intervention (scores range from 4-20)
Time Frame
at study completion, an average of 8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG. Persons with Alzheimer's Disease (investigators anticipate cognitive impairment within this group) 18 years old or older Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score < 4) Able to read and speak English (intervention in English) Caregivers (CG) > 18 years old Non-paid (eliminates professional caregivers) Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report) Able to read and speak English (written materials in English) No diagnosis of cognitive impairment Exclusion Criteria: Inability or unwillingness to provide informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
MaryChris Pittman
Phone
843-792-3512
Email
pittmama@musc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Diana Layne, PhD
Phone
843-792-6698
Email
layne@musc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diana M Layne, PhD
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
MaryChris Pittman
Phone
843-792-3512
Email
pittmama@musc.edu
First Name & Middle Initial & Last Name & Degree
Diana Layne, PhD
Phone
843-792-6698
Email
layne@musc.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

We'll reach out to this number within 24 hrs